# Galectin Therapeutics Inc: Form DEF 14A, filed Dec 3, 2024

- Company: [Galectin Therapeutics Inc](/companies/galt.md) (CIK 1133416)
- Form: DEF 14A
- Filed: 2024-12-03
- Accepted by EDGAR: Dec 3, 2024, 13:03 ET
- Period: 2025-01-23
- Accession: 0001140361-24-048239
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1133416/000114036124048239/ny20035571x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1133416/000114036124048239/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1133416/000114036124048239/ny20035571x1_def14a.htm

Filed Dec 3, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-048239. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.